Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$127.77 - $221.42 $24,148 - $41,848
-189 Reduced 0.58%
32,342 $7.02 Million
Q3 2023

Nov 13, 2023

SELL
$154.67 - $290.89 $1.78 Million - $3.35 Million
-11,531 Reduced 26.17%
32,531 $5.19 Million
Q2 2023

Aug 11, 2023

SELL
$272.48 - $330.23 $807,903 - $979,131
-2,965 Reduced 6.3%
44,062 $12.7 Million
Q1 2023

May 15, 2023

SELL
$276.36 - $326.03 $500,487 - $590,440
-1,811 Reduced 3.71%
47,027 $15 Million
Q4 2022

Feb 14, 2023

BUY
$212.22 - $313.46 $43,929 - $64,886
207 Added 0.43%
48,838 $14.4 Million
Q3 2022

Nov 14, 2022

BUY
$224.6 - $281.45 $1.08 Million - $1.36 Million
4,822 Added 11.01%
48,631 $11.2 Million
Q2 2022

Aug 15, 2022

SELL
$186.4 - $279.02 $1.24 Million - $1.86 Million
-6,661 Reduced 13.2%
43,809 $9.55 Million
Q1 2022

May 16, 2022

BUY
$194.8 - $275.7 $855,561 - $1.21 Million
4,392 Added 9.53%
50,470 $13.4 Million
Q4 2021

Feb 14, 2022

BUY
$255.32 - $318.29 $662,044 - $825,325
2,593 Added 5.96%
46,078 $12.3 Million
Q3 2021

Nov 15, 2021

SELL
$260.36 - $307.27 $132,262 - $156,093
-508 Reduced 1.15%
43,485 $12.4 Million
Q2 2021

Aug 16, 2021

BUY
$225.52 - $304.06 $735,420 - $991,539
3,261 Added 8.01%
43,993 $12.1 Million
Q1 2021

May 14, 2021

SELL
$235.95 - $293.05 $790,668 - $982,010
-3,351 Reduced 7.6%
40,732 $10.6 Million
Q3 2020

Nov 13, 2020

BUY
$192.55 - $236.59 $1.38 Million - $1.7 Million
7,165 Added 19.41%
44,083 $10.4 Million
Q2 2020

Aug 14, 2020

BUY
$159.17 - $224.73 $692,230 - $977,350
4,349 Added 13.35%
36,918 $7.17 Million
Q1 2020

May 15, 2020

BUY
$130.01 - $216.44 $4.23 Million - $7.05 Million
32,569 New
32,569 $5.4 Million

Others Institutions Holding PODD

About INSULET CORP


  • Ticker PODD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 69,403,600
  • Market Cap $18.1B
  • Description
  • Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...
More about PODD
Track This Portfolio

Track Capital International LTD Portfolio

Follow Capital International LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International LTD , based on Form 13F filings with the SEC.

News

Stay updated on Capital International LTD with notifications on news.